Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1446

2.
3.

Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).

Jones RN, Sader HS, Fritsche TR, Pottumarthy S.

Diagn Microbiol Infect Dis. 2007 Jan;57(1):109-16. Epub 2006 Aug 23.

PMID:
16930923
[PubMed - indexed for MEDLINE]
4.

Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.

Zhanel GG, DeCorby M, Laing N, Weshnoweski B, Vashisht R, Tailor F, Nichol KA, Wierzbowski A, Baudry PJ, Karlowsky JA, Lagacé-Wiens P, Walkty A, McCracken M, Mulvey MR, Johnson J; Canadian Antimicrobial Resistance Alliance (CARA), Hoban DJ.

Antimicrob Agents Chemother. 2008 Apr;52(4):1430-7. doi: 10.1128/AAC.01538-07. Epub 2008 Feb 19.

PMID:
18285482
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000).

Hoban DJ, Biedenbach DJ, Mutnick AH, Jones RN.

Diagn Microbiol Infect Dis. 2003 Apr;45(4):279-85.

PMID:
12730000
[PubMed - indexed for MEDLINE]
6.

Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America).

Mathai D, Jones RN, Pfaller MA; SENTRY Participant Group North America.

Diagn Microbiol Infect Dis. 2001 Jul;40(3):129-36.

PMID:
11502382
[PubMed - indexed for MEDLINE]
7.
8.

Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.

Sader HS, Jones RN, Dowzicky MJ, Fritsche TR.

Diagn Microbiol Infect Dis. 2005 Jul;52(3):203-8.

PMID:
16105565
[PubMed - indexed for MEDLINE]
9.

Argentinean collaborative multicenter study on the in vitro comparative activity of piperacillin-tazobactam against selected bacterial isolates recovered from hospitalized patients.

Casellas JM, Tomé G, Bantar C, Bertolini P, Blázquez N, Borda N, Couto E, Cudmani N, Guerrera J, Juárez MJ, López T, Littvik A, Méndez E, Notario R, Ponce G, Quinteros M, Salamone F, Sparo M, Sutich E, Vaylet S, Wolff L.

Diagn Microbiol Infect Dis. 2003 Nov;47(3):527-37.

PMID:
14596972
[PubMed - indexed for MEDLINE]
10.

Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006.

Zhanel GG, DeCorby M, Nichol KA, Wierzbowski A, Baudry PJ, Karlowsky JA, Lagacé-Wiens P, Walkty A, Mulvey MR, Hoban DJ; Canadian Antimicrobial Resistance Alliance.

Diagn Microbiol Infect Dis. 2008 Sep;62(1):67-80. doi: 10.1016/j.diagmicrobio.2008.04.012. Epub 2008 May 29.

PMID:
18513913
[PubMed - indexed for MEDLINE]
11.

Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).

Nørskov-Lauritsen N, Marchandin H, Dowzicky MJ.

Int J Antimicrob Agents. 2009 Aug;34(2):121-30. doi: 10.1016/j.ijantimicag.2009.02.003. Epub 2009 Apr 1.

PMID:
19342205
[PubMed - indexed for MEDLINE]
12.

Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers.

Sader HS, Jones RN, Andrade-Baiocchi S, Biedenbach DJ; SENTRY Participants Group (Latin America).

Diagn Microbiol Infect Dis. 2002 Nov;44(3):273-80.

PMID:
12493175
[PubMed - indexed for MEDLINE]
13.

Comparison of antimicrobial use and resistance of bacterial isolates in a haematology ward and an intensive care unit.

Lang A, De Fina G, Meyer R, Aschbacher R, Rizza F, Mayr O, Casini M.

Eur J Clin Microbiol Infect Dis. 2001 Sep;20(9):657-60.

PMID:
11714050
[PubMed - indexed for MEDLINE]
14.
16.

Prevalence and antibiotic sensitivity of Danish versus other European bacterial isolates from intensive care and hematology/oncology units.

Fomsgaard A, Høiby N, Friis HM, Gahrn-Hansen B, Kolmos HJ, Schouenborg P, Korsager B, Tvede M, Gutschik E, Bremmelgaard A.

Eur J Clin Microbiol Infect Dis. 1995 Apr;14(4):275-81.

PMID:
7649189
[PubMed - indexed for MEDLINE]
17.

Evaluation of the in vitro activity of 9 antimicrobials against bacterial strains isolated from patients in intensive care units in brazil: MYSTIC Antimicrobial Surveillance Program.

Mendes C, Hsiung A, Kiffer C, Oplustil C, Sinto S, Mimica I, Zoccoli C; Mystic Study Group.

Braz J Infect Dis. 2000 Oct;4(5):236-44.

PMID:
11063555
[PubMed - indexed for MEDLINE]
18.

Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).

Watters AA, Jones RN, Leeds JA, Denys G, Sader HS, Fritsche TR.

J Antimicrob Chemother. 2006 May;57(5):914-23. Epub 2006 Mar 20.

PMID:
16549511
[PubMed - indexed for MEDLINE]
Free Article
19.

Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000).

Rennie RP, Jones RN, Mutnick AH; SENTRY Program Study Group (North America).

Diagn Microbiol Infect Dis. 2003 Apr;45(4):287-93.

PMID:
12730001
[PubMed - indexed for MEDLINE]
20.

Antimicrobial susceptibility of gram-positive bacteria isolated in Brazilian hospitals participating in the SENTRY Program (2005-2008).

Gales AC, Sader HS, Ribeiro J, Zoccoli C, Barth A, Pignatari AC.

Braz J Infect Dis. 2009 Apr;13(2):90-8.

PMID:
20140350
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk